Envista Holdings Corporation (FRA:0HV)
Germany · Delayed Price · Currency is EUR | Market Cap | 3.78B +22.8% |
| Revenue (ttm) | 2.50B +11.9% |
| Net Income | 83.05M +76.6% |
| EPS | 0.50 +84.1% |
| Shares Out | n/a |
| PE Ratio | 45.52 |
| Forward PE | 17.33 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 23.20 |
| Previous Close | 23.00 |
| Day's Range | 22.80 - 23.20 |
| 52-Week Range | 16.90 - 24.60 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About Envista Holdings
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, ... [Read more]
News
Envista price target raised to $23 from $21 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Envista (NVST) to $23 from $21 and keeps an Equal Weight rating on the shares. Envista delivered a solid Q2 beat and…
Envista price target raised to $34 from $31 at Baird
Baird raised the firm’s price target on Envista (NVST) to $34 from $31 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results as…
Envista price target raised to $28 from $26 at Piper Sandler
Piper Sandler analyst Jason Bednar raised the firm’s price target on Envista (NVST) to $28 from $26 and keeps a Neutral rating on the shares. The firm notes the company…
Envista price target raised to $29 from $27 at Mizuho
Mizuho raised the firm’s price target on Envista (NVST) to $29 from $27 and keeps a Neutral rating on the shares.
Envista Holdings Earnings Call Transcript: Q2 2026
Q2 2026 saw 5% core growth, 28% adjusted EBITDA growth, and 58% EPS growth, with strong performance across all segments and geographies. Guidance for 2026 was raised, reflecting continued momentum, robust cash flow, and ongoing innovation.
Envista Holdings Earnings release: Q2 2026
Envista Holdings released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
Envista Holdings Slides: Q2 2026
Envista Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
Envista Holdings Quarterly report: Q2 2026
Envista Holdings has published its Q2 2026 quarterly earnings report on August 5, 2026.
Envista Reports Second Quarter 2026 Results
BREA, Calif., Aug. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended July 3, 2026.
Envista price target raised to $26 from $25 at Piper Sandler
Piper Sandler raised the firm’s price target on Envista (NVST) to $26 from $25 and keeps a Neutral rating on the shares. Investors have been conditioned to expect beats from…
Envista to Host Investor Day on September 17, 2026
BREA, Calif., July 28, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will hold an Investor Day on Thursday, September 17, from 9:00 a.m.
Envista initiated with a Market Perform at BMO Capital
BMO Capital analyst Vik Chopra initiated coverage of Envista (NVST) with a Market Perform rating and $27 price target The company’s turnaround is real and its CEO has earned credibility,…
Envista Schedules Second Quarter 2026 Earnings Call
BREA, Calif., July 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2026 on Wednesday, August 5, 2026.
Envista price target lowered to $32 from $34 at Barclays
Barclays lowered the firm’s price target on Envista (NVST) to $32 from $34 and keeps an Overweight rating on the shares. The firm says the company’s end markets continue to…
Envista Holdings Transcript: AGM 2026
The meeting covered board elections, auditor ratification, and executive compensation, with all proposals passing by majority vote. A quorum was present, and no stockholder questions were submitted during the Q&A session.
Envista price target raised to $31 from $30 at Baird
Baird analyst Jeff Johnson raised the firm’s price target on Envista (NVST) to $31 from $30 and keeps an Outperform rating on the shares. The firm updated its model following…
Envista price target raised to $29 from $26 at JPMorgan
JPMorgan raised the firm’s price target on Envista (NVST) to $29 from $26 and keeps a Neutral rating on the shares.
Envista price target raised to $33 from $30 at Evercore ISI
Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Envista (NVST) to $33 from $30 and keeps an Outperform rating on the shares.
Envista Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw double-digit sales, adjusted EBITDA, and EPS growth, driven by broad-based segment and geographic performance. Operational improvements and continued investment in innovation supported margin expansion, while the board authorized a $300 million share repurchase and reaffirmed 2026 guidance.
Envista Holdings Earnings release: Q1 2026
Envista Holdings released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Envista Holdings Quarterly report: Q1 2026
Envista Holdings has published its Q1 2026 quarterly earnings report on May 6, 2026.
Envista Holdings Slides: Q1 2026
Envista Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Envista Reports First Quarter 2026 Results
BREA, Calif., May 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended April 3, 2026.
Envista price target raised to $21 from $19 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Envista (NVST) to $21 from $19 and keeps an Equal Weight rating on the shares. The firm’s U.S. dental survey suggests softer…
Envista initiated with a Neutral at Citi
Citi analyst Daniel Grosslight initiated coverage of Envista (NVST) with a Neutral rating and $29 price target The firm launched the animal health and dental sectors with a “cautiously optimistic”…